<code id='941910714E'></code><style id='941910714E'></style>
    • <acronym id='941910714E'></acronym>
      <center id='941910714E'><center id='941910714E'><tfoot id='941910714E'></tfoot></center><abbr id='941910714E'><dir id='941910714E'><tfoot id='941910714E'></tfoot><noframes id='941910714E'>

    • <optgroup id='941910714E'><strike id='941910714E'><sup id='941910714E'></sup></strike><code id='941910714E'></code></optgroup>
        1. <b id='941910714E'><label id='941910714E'><select id='941910714E'><dt id='941910714E'><span id='941910714E'></span></dt></select></label></b><u id='941910714E'></u>
          <i id='941910714E'><strike id='941910714E'><tt id='941910714E'><pre id='941910714E'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:9
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Pioneering cancer drug will cost $475,000. Analysts call it a bargain
          Pioneering cancer drug will cost $475,000. Analysts call it a bargain

          VictorSeguraIbarraandRitaSerda,Ph.D.,NCI,NIHTheFoodandDrugAdministrationonWednesdayapprovedafuturist

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Twill hunts for pharma partner to market its depression app

          AlexHogan/STATInanothersignofthebusinessheadwindsfacingprescriptionmentalhealthapps,developerTwillwi